Effiskin(r), a veterinary hygiene product adapted to dogs with pyoderma prone skins

  • Alphanosos
  • From France
  • Responsive
  • Innovative Products and Technologies

Summary of the technology

We are looking for distributors and/or licensees for Effiskin(r). This hygiene product is a lotion formulated around our patent pending alternative to antibiotics and chlorhexidine, a WECMEP (Water Extracts of Complex Mixes of Edible Plants) with a great safety profile. Successful animal model results and user testimony are available. Available as bulk formulation or finished product (spray), also for rebranding.


Current development status

Commercially available technology, sales started in France and Switzerland

Desired business relationship

Provider of bulk formulation and/or finished product with our without rebranding.

Patent licensing.

Intellectual property status

Patent already applied for

Patent application number: WO2018083115

Where: Worldwide

Attached documents

Related Keywords

  • Soaps, detergents
  • Care, Hygiene, Beauty, Cosmetics
  • Environmental Medicine, Social Medicine, Sports Medicine
  • Virus, Virology / Antibiotics / Bacteriology
  • Veterinary Medicine
  • Medical Health related
  • Environmental Medicine, Social Medicine,Sports Medicine
  • Plant and animal health
  • Animal health
  • Consumer related
  • Consumer Products
  • Health and beautty aids, Cosmetics
  • veterinary
  • hygiene

About Alphanosos

Alphanosos is a privately held company incorporated in November 2014 in France. We are leveraging our disruptive, AI-based, proprietary discovery process to discover and patent active ingredients and products based on plants with a history of safe human consumption to replace, with superior efficacy and reduced risks of side effects, many of the chemical products used as therapeutic drugs in the human and animal health industries. We concentrate our discovery efforts on the selective killing of deleterious micro-organisms and cells. Our initial focus is on new antibiotics and anti-cancer products, with first products already in the post-discovery phase and a first patent application on anti-staphylococci products, for which we already obtained topical and systemic animal model results. Early revenue is already generated by licenses for cosmetic usage of certain of these products, to be soon followed with licenses for veterinary applications and later for human drugs.


Never miss an update from Alphanosos

Create your free account to connect with Alphanosos and thousands of other innovative organizations and professionals worldwide


Send a request for information
to Alphanosos

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.


Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support